Medibiofarma S.L.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients (NCT06469853) | Medibiofarma S.L. | 2024-02-01 |
| Safety and Efficacy of MBF-118 in Patients with Crohn Disease (NCT05940558) | Medibiofarma S.L. | 2023-04-12 |
| First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors (NCT05940571) | Medibiofarma S.L. | 2022-11-24 |
| Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers (NCT06049147) | Medibiofarma S.L. | 2021-07-07 |
| Study to Assess the Safety and Tolerability of MBF-118 in Healthy Volunteers (NCT05921916) | Medibiofarma S.L. | 2020-07-03 |
Track Medibiofarma S.L. automatically
Every clearance here is in the API, with alerts when new ones post.